MedComm – Biomaterials and Applications is a peer-reviewed english-language open-access journal published by Wiley in Australia, operating under an open-access model since 2022. The journal covers Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials and Medicine (General): Medical technology.
Authors are required to pay an article processing charge to publish in MedComm – Biomaterials and Applications; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, MedComm – Biomaterials and Applications has published 173 articles. Articles are minted with DOIs through the prefix 10.1002. All submissions undergo plagiarism screening before peer review.
Keywords
biomaterials, biomedical devices, medical technology, materials science
At a glance
- Publisher
- Wiley
- Country
- Australia
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2022
- Review time
- 15 weeks
- DOI prefix
10.1002- Plagiarism check
- Yes
ISSN
- electronic
- 2769-643X
Frequently asked questions
Is MedComm – Biomaterials and Applications peer-reviewed?
Does MedComm – Biomaterials and Applications charge an article processing charge (APC)?
What subjects does MedComm – Biomaterials and Applications publish?
What languages does MedComm – Biomaterials and Applications accept?
What is the ISSN of MedComm – Biomaterials and Applications?
2769-643X (electronic).